
    inclusion speed
  
['advanced non-small cell lung cancer']
['pemetrexed with bevacizumab']

        Inclusion Criteria:

          -  20 Years and older

          -  PS0-2

          -  Advanced non-squamous non-small cell lung cancer; AND

          -  Patients who have received more than 4 cycles of pemetrexed therapy before the study

        Exclusion Criteria:

          -  Interstitial pneumonia; AND

          -  Abnormal blood test
      